Celltrion & K-Bio: South Korea’s Trade Policy Shaping Global Exports
South Korea’s strategic trade policies are driving K-Bio’s global expansion, with Celltrion leading in biopharma export strategy and market access challenges.
K-Bio
South Korea’s Quest for a Blockbuster Drug: The Rise of ADCs in the K-Bio Landscape
The success story of Enhertu, a pioneering ADC developed by Daiichi Sankyo and AstraZeneca, has catalyzed a global frenzy in ADC research and development. Achieving blockbuster status within three years of its launch, with sales surpassing $2.6 billion, Enhertu’s triumph underscores the potential of ADCs in transforming cancer treatment. This has spurred a race among … Read more